Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Chatain

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Molecular Carcinogenesis|November 7, 2019
LCP1 triggers mTORC2/AKT activity and is pharmacologically targeted by enzastaurin in hypereosinophiliaGuangxin Ma, Deniz Gezer, Oliver Herrmann, et al.
ACS Medicinal Chemistry Letters|October 16, 2020
Chiral Analogues of PFI-1 as BET Inhibitors and Their Functional Role in Myeloid MalignanciesBianca Altenburg, Marcus Frings, Jan-Hendrik Schöbel, et al.
Scientific Reports|February 2, 2024
Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasmsKristin Holl, Nicolas Chatain, Susanne Krapp, et al.
The Journal of Biological Chemistry|December 4, 2010
Splice variants of the dual specificity tyrosine phosphorylation-regulated kinase 4 (DYRK4) differ in their subcellular localization and catalytic activityChrisovalantis Papadopoulos, Krisztina Arato, Eva Lilienthal, et al.
Oncotarget|April 21, 2017
The SCLtTAxBCR-ABL transgenic mouse model closely reflects the differential effects of dasatinib on normal and malignant hematopoiesis in chronic phase-CML patientsClaudia Schubert, Nicolas Chatain, Till Braunschweig, et al.
Scientific Reports|June 6, 2019
Hematopoietic stem and progenitor cell proliferation and differentiation requires the trithorax protein Ash2lJuliane Lüscher-Firzlaff, Nicolas Chatain, Chao-Chung Kuo, et al.
Annals of Hematology|November 22, 2019
Transcriptional alteration of DNA repair genes in Philadelphia chromosome negative myeloproliferative neoplasmsMartin Kirschner, Anne Bornemann, Claudia Schubert, et al.
Cell Communication and Signaling : CCS|March 21, 2024
Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entryVikas Bhuria, Tobias Franz, Conny Baldauf, et al.
Scientific Reports|October 19, 2016
Intramolecular hydrophobic interactions are critical mediators of STAT5 dimerizationDirk Fahrenkamp, Jinyu Li, Sabrina Ernst, et al.
Stem Cell Research|August 14, 2021
CRISPR/Cas9 mediated CXCL4 knockout in human iPS cells of polycythemia vera patient with JAK2 V617F mutationJanik Boehnke, Salim Atakhanov, Marcelo A S Toledo, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Molecular Carcinogenesis|November 7, 2019
LCP1 triggers mTORC2/AKT activity and is pharmacologically targeted by enzastaurin in hypereosinophiliaGuangxin Ma, Deniz Gezer, Oliver Herrmann, et al.
ACS Medicinal Chemistry Letters|October 16, 2020
Chiral Analogues of PFI-1 as BET Inhibitors and Their Functional Role in Myeloid MalignanciesBianca Altenburg, Marcus Frings, Jan-Hendrik Schöbel, et al.
Scientific Reports|February 2, 2024
Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasmsKristin Holl, Nicolas Chatain, Susanne Krapp, et al.
The Journal of Biological Chemistry|December 4, 2010
Splice variants of the dual specificity tyrosine phosphorylation-regulated kinase 4 (DYRK4) differ in their subcellular localization and catalytic activityChrisovalantis Papadopoulos, Krisztina Arato, Eva Lilienthal, et al.
Oncotarget|April 21, 2017
The SCLtTAxBCR-ABL transgenic mouse model closely reflects the differential effects of dasatinib on normal and malignant hematopoiesis in chronic phase-CML patientsClaudia Schubert, Nicolas Chatain, Till Braunschweig, et al.
Scientific Reports|June 6, 2019
Hematopoietic stem and progenitor cell proliferation and differentiation requires the trithorax protein Ash2lJuliane Lüscher-Firzlaff, Nicolas Chatain, Chao-Chung Kuo, et al.
Annals of Hematology|November 22, 2019
Transcriptional alteration of DNA repair genes in Philadelphia chromosome negative myeloproliferative neoplasmsMartin Kirschner, Anne Bornemann, Claudia Schubert, et al.
Cell Communication and Signaling : CCS|March 21, 2024
Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entryVikas Bhuria, Tobias Franz, Conny Baldauf, et al.
Scientific Reports|October 19, 2016
Intramolecular hydrophobic interactions are critical mediators of STAT5 dimerizationDirk Fahrenkamp, Jinyu Li, Sabrina Ernst, et al.
Stem Cell Research|August 14, 2021
CRISPR/Cas9 mediated CXCL4 knockout in human iPS cells of polycythemia vera patient with JAK2 V617F mutationJanik Boehnke, Salim Atakhanov, Marcelo A S Toledo, et al.
Pageof 5